Clinical Trial Update: Safety and Preliminary Efficacy of NXL-001 in Patients with Ischemic Stroke [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update for NXL-001 in ischemic stroke notes that the study is not yet recruiting. It centers on safety and preliminary efficacy objectives.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NXL-001

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke | EARLY_Phase 1 | Status: NOT_YET_RECRUITING